NO773245L - Fremgangsmaate for fremstilling av nye triazolopyridaziner - Google Patents
Fremgangsmaate for fremstilling av nye triazolopyridazinerInfo
- Publication number
- NO773245L NO773245L NO773245A NO773245A NO773245L NO 773245 L NO773245 L NO 773245L NO 773245 A NO773245 A NO 773245A NO 773245 A NO773245 A NO 773245A NO 773245 L NO773245 L NO 773245L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- methyl
- trifluoromethyl
- group
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/725,597 US4230705A (en) | 1976-09-22 | 1976-09-22 | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety |
| US73039576A | 1976-10-07 | 1976-10-07 | |
| US73547576A | 1976-10-26 | 1976-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO773245L true NO773245L (no) | 1978-03-28 |
Family
ID=27419081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO773245A NO773245L (no) | 1976-09-22 | 1977-09-21 | Fremgangsmaate for fremstilling av nye triazolopyridaziner |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5340798A (fr) |
| AR (2) | AR218036A1 (fr) |
| AT (1) | AT360034B (fr) |
| AU (1) | AU513760B2 (fr) |
| BG (1) | BG29287A3 (fr) |
| CA (1) | CA1080712A (fr) |
| DD (1) | DD132586A5 (fr) |
| DE (1) | DE2741763A1 (fr) |
| DK (1) | DK417377A (fr) |
| ES (3) | ES462543A1 (fr) |
| FI (1) | FI772802A7 (fr) |
| FR (1) | FR2442848A1 (fr) |
| GB (1) | GB1589237A (fr) |
| GR (1) | GR71699B (fr) |
| LU (1) | LU78150A1 (fr) |
| NL (1) | NL7710389A (fr) |
| NO (1) | NO773245L (fr) |
| PT (1) | PT67067B (fr) |
| RO (1) | RO72226A (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR70309B (fr) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co | |
| FR2473522A1 (fr) * | 1980-01-16 | 1981-07-17 | Synthelabo | Nouveaux derives substitues de dihydro-2,3 imidazo(1,2-b)pyridazines et les medicaments, utiles notamment comme antidepresseurs, qui en contiennent |
| EP0036711B1 (fr) * | 1980-03-22 | 1985-12-04 | Fbc Limited | Composés hétérocycliques pesticides, procédés pour leur préparation, compositions les contenant, et leur utilisation |
| DE3217325A1 (de) * | 1982-05-08 | 1983-11-10 | Hoechst Ag, 6230 Frankfurt | 3-amino-6-aryl-1,2,4-triazolo(4,3-b)-pyridazine, ihre herstellung und ihre verwendung |
| US4487930A (en) * | 1982-09-07 | 1984-12-11 | The Dow Chemical Company | 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines |
| FR2562071B1 (fr) * | 1984-03-30 | 1986-12-19 | Sanofi Sa | Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US4767765A (en) * | 1985-10-31 | 1988-08-30 | American Cyanamid Company | N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| US4654343A (en) * | 1985-10-31 | 1987-03-31 | American Cyanamid Company | N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| EP0915875B1 (fr) | 1996-07-25 | 2003-04-09 | MERCK SHARP & DOHME LTD. | Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba |
| AU746866B2 (en) * | 1998-01-14 | 2002-05-02 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for GABA receptors |
| GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| MXPA00007135A (es) * | 1998-01-21 | 2002-11-07 | Merck Sharp & Dohme | Derivados de triazolo-piridazina como ligandos para receptores gaba. |
| GB9801208D0 (en) * | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801234D0 (en) * | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801397D0 (en) | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| WO2005077953A1 (fr) * | 2004-02-18 | 2005-08-25 | Banyu Pharmaceutical Co., Ltd. | Dérivé azoté de noyau hétéroaromatique fusionné |
| CA3281817A1 (en) | 2016-11-28 | 2026-03-02 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| IL309843B2 (en) * | 2018-05-30 | 2026-05-01 | Praxis Prec Medicines Inc | History of [4,2,1]triazolo[3,4-a]pyridines and their use as sodium ion channel modulators |
| EA202092908A1 (ru) | 2018-09-28 | 2021-05-14 | Праксис Пресижн Медсинз, Инк. | Модуляторы ионных каналов |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| PE20221280A1 (es) | 2019-11-27 | 2022-09-05 | Praxis Prec Medicines Inc | Formulaciones de moduladores de canales ionicos y metodos de preparacion y uso de moduladores de canales ionicos |
| CN115087657B (zh) * | 2019-12-18 | 2025-01-21 | 加利福尼亚大学董事会 | Lin28抑制剂和其使用方法 |
| KR20250005348A (ko) | 2022-04-26 | 2025-01-09 | 프락시스 프리시젼 메디신즈, 인크. | 신경 장애의 치료 |
-
1977
- 1977-08-16 CA CA284,806A patent/CA1080712A/fr not_active Expired
- 1977-08-19 GR GR54197A patent/GR71699B/el unknown
- 1977-09-07 AR AR269126A patent/AR218036A1/es active
- 1977-09-16 DE DE19772741763 patent/DE2741763A1/de not_active Withdrawn
- 1977-09-20 RO RO7791618A patent/RO72226A/fr unknown
- 1977-09-20 LU LU78150A patent/LU78150A1/xx unknown
- 1977-09-20 BG BG037371A patent/BG29287A3/xx unknown
- 1977-09-21 NO NO773245A patent/NO773245L/no unknown
- 1977-09-21 AT AT677577A patent/AT360034B/de not_active IP Right Cessation
- 1977-09-21 DK DK417377A patent/DK417377A/da unknown
- 1977-09-21 AU AU28995/77A patent/AU513760B2/en not_active Expired
- 1977-09-22 FR FR7728639A patent/FR2442848A1/fr active Pending
- 1977-09-22 NL NL7710389A patent/NL7710389A/xx not_active Application Discontinuation
- 1977-09-22 JP JP11344877A patent/JPS5340798A/ja active Pending
- 1977-09-22 FI FI772802A patent/FI772802A7/fi not_active Application Discontinuation
- 1977-09-22 PT PT67067A patent/PT67067B/pt unknown
- 1977-09-22 DD DD7700201157A patent/DD132586A5/xx unknown
- 1977-09-22 GB GB39619/77A patent/GB1589237A/en not_active Expired
- 1977-09-22 ES ES462543A patent/ES462543A1/es not_active Expired
-
1978
- 1978-12-18 AR AR274489A patent/AR217886A1/es active
-
1979
- 1979-02-16 ES ES477799A patent/ES477799A1/es not_active Expired
- 1979-02-16 ES ES477800A patent/ES477800A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| LU78150A1 (fr) | 1978-01-23 |
| DD132586A5 (de) | 1978-10-11 |
| FR2442848A1 (fr) | 1980-06-27 |
| ES462543A1 (es) | 1979-06-16 |
| DE2741763A1 (de) | 1978-03-23 |
| JPS5340798A (en) | 1978-04-13 |
| ES477800A1 (es) | 1979-10-16 |
| DK417377A (da) | 1978-03-23 |
| BG29287A3 (bg) | 1980-10-15 |
| PT67067A (en) | 1977-10-01 |
| NL7710389A (nl) | 1978-03-28 |
| GR71699B (fr) | 1983-06-21 |
| PT67067B (en) | 1979-02-19 |
| AT360034B (de) | 1980-12-10 |
| ES477799A1 (es) | 1980-04-01 |
| RO72226A (fr) | 1982-09-09 |
| GB1589237A (en) | 1981-05-07 |
| AU2899577A (en) | 1979-03-29 |
| CA1080712A (fr) | 1980-07-01 |
| AR217886A1 (es) | 1980-04-30 |
| AU513760B2 (en) | 1980-12-18 |
| FI772802A7 (fi) | 1978-03-23 |
| ATA677577A (de) | 1980-05-15 |
| AR218036A1 (es) | 1980-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4112095A (en) | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents | |
| US4230705A (en) | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety | |
| GB1589237A (en) | Substituted 6 - phenyl - 1,2,4 - triazolo-((4,3-b)pyridazines | |
| KR900004833B1 (ko) | N-치환-N-[3-(1,2,4-트리아졸로[4,3-b]피리다진-6-일)페닐]알칸아미드, 카바메이트 및 우레아 화합물과 그 제조 방법 및 조성물 | |
| CA1234114A (fr) | Derives de triazole¬3,4-a|phthalazine substitues en positions 3 et 6 | |
| NO851862L (no) | Fremgangsmaate ved fremstilling av nye pyrrolobenzimidazoler | |
| US4260755A (en) | Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines | |
| EP1149102A1 (fr) | Derives de triazolo-pyridazine tenant lieu de ligands pour recepteurs gaba | |
| EP0029103B1 (fr) | 6- ou 8-Hétéroaryl-1,2,4-triazolo(4,3-b)pyridazines | |
| EP1049696A1 (fr) | Derives de la triazolo-pyridazine, ligands des recepteurs du gaba | |
| CA1305703C (fr) | 4-5-dihydro et 4,5,6,7-tetrahydropyrazolo-[1,5-a] pyrimidines | |
| AU748013B2 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
| US4117130A (en) | Method for treating anxiety in mammals | |
| CA2298522C (fr) | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique | |
| NO156011B (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 3, 6, 7, 8-substituerte-s-triazolo (4,3-b) pyridaziner. | |
| US4569934A (en) | Imidazo[1,2-b]pyridazines | |
| EP1056748A1 (fr) | Derives de triazolo-pyridazine utiles comme ligands pour les recepteurs gaba | |
| Biagi et al. | New 1, 2, 3‐triazolo [4, 5‐d] 1, 2, 4‐triazolo [3, 4‐b] pyridazine derivatives II | |
| EP1150983A1 (fr) | Derives de la triazolo-pyridazine, liants des recepteurs du gaba | |
| US4482714A (en) | Pyrazino[2',3'-3,4]pyrido[1,2-a]indole derivatives | |
| DD215545A5 (de) | Verfahren zur herstellung eines (1,2,4)triazolo (4,3-a)chin-oxalin-4-amin-derivats | |
| US4372956A (en) | 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them | |
| US4767765A (en) | N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas | |
| US4515949A (en) | [2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals | |
| US5242918A (en) | Isatinoxime derivatives, their preparation and use |